コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ciated with a series of in vitro and in vivo immune abnormalities consistent with lymphocyte hyperact
3 ntal animal models demonstrate that maternal immune activation (MIA) elevates inflammatory cytokine l
4 work density and/or morphology can result in immune activation or, as recently implicated, in providi
6 ptionally characterized by markers of type-2 immune activation, inflammation, cellular infiltration,
10 ed to exhibit chronically elevated levels of immune activity, had significantly higher CD4+CD151+ T-c
13 whole representative data characterizing the immune and inflammatory status in coronavirus disease 20
14 els were characterized at histopathological, immune, and transcriptomic level to identify the unique
16 Our results suggest that the microbiome-gut-immune axis can be modified by DEHP and emphasize the va
17 several hundred clinical trials have tested immune-based approaches in childhood cancers, few have b
18 tients with liver injury is indicative of an immune-based mechanism for the observed hepatic enzyme e
21 small alpha-helical cytokine that regulates immune cell homeostasis through its recruitment to a hig
28 portunities to enhance the sophistication of immune cell therapies, increasing potency and safety and
30 lated genes that were similarly expressed in immune cells (hemocytes) and ovarian somatic cells (stre
31 This differs from lymphoid organs, in which immune cells adopt spatially biased positions to promote
32 omarker analysis to characterize the role of immune cells and inhibitory checkpoints, genome-wide fre
40 e chitin released from hemocytes (phagocytic immune cells) that traffic into the light-organ crypts,
42 d expression of inflammatory genes in innate immune cells, potentially explaining the link between mu
51 Despite the outstanding clinical results of immune checkpoint blockade (ICB) in melanoma and other c
52 ed stage IIIB-IV NSCLC who were treated with immune checkpoint blockade between June 2011 and Decembe
55 in a variety of cancer subtypes, the role of immune checkpoint inhibition in the treatment of prostat
58 , proton pump inhibitor use, and combination immune checkpoint inhibitor therapy were each independen
63 e than cutaneous melanoma to chemotherapy or immune checkpoint inhibitors, encouraging results have b
65 ress the issue of patient stratification for immune checkpoint intervention, we quantitatively imaged
68 4) in vitro after activation with zymosan or immune complexes, compared with wild-type (WT) neutrophi
69 (SIgA) is the single most abundant acquired immune component secreted onto mucosal surfaces and, via
70 multiple alterations associated with better immune control: increased infiltration and activation of
71 plant lymphoproliferative disorder; however, immune correlates of EBV DNAemia in the transplant setti
72 lammasomes are important sentinels of innate immune defence that are activated in response to diverse
77 itis virus (LCMV) clone 13 (CL13), result in immune dysfunction that predisposes the host to severe i
78 e the transcriptional profile of this airway immune dysfunction, we performed the first single-cell t
80 Thus, data indicate that CVID-associated immune dysregulation is a T(H)1-mediated inflammatory pr
81 th mosaic expression that drives multi-organ immune dysregulation via kinase dependent and independen
84 ts the need to understand the role of innate immune effectors in the complex interactions between inf
85 nockdown had a particularly strong effect on immune effectors that are predominantly activated by the
89 -immunity and antigenic mutations that allow immune escape impact influenza epidemic dynamics at the
90 jor B-cell lymphomas with an emphasis on the immune escape pathways orchestrated by these diseases.
93 Thus, cancer methionine consumption is an immune evasion mechanism, and targeting cancer methionin
94 on and that PD-L1 expression is an important immune evasion strategy used by KSHV for its survival an
96 nostimulatory Ypt and Ye strains, but not in immune-evasive Yp Analysis of Yp pagP gene sequences ide
97 It is unclear if the flu vaccine exacerbates immune events in patients treated with immune checkpoint
98 nto mucosal surfaces and, via the process of immune exclusion, shapes the architecture of these micro
102 s and its implication in the pathogenesis of immune function and the development of CF lung disease.M
103 y mass and moult, showed that an increase in immune function was associated with a decrease in body m
109 tional T cells, much less is known about the immune functions of unconventional T cells and their rol
110 ral pathogens, antibodies mediate additional immune functions that may have both protective and patho
111 Exomic studies have demonstrated that innate immune genes exhibit an even higher degree of variation
112 standard of care treatment with intravenous immune globulin + rituximab with or without plasma excha
114 GLOB), antioxidants (SOD, GPx and GSH), and immune (IgM and lysozyme) parameters in LMB, except ALP
116 he expression of the recently characterized, immune-inducible gene Induced by Infection (IBIN) was di
117 umber of deleted genes while those with high immune infiltrate expressed higher levels of adaptive re
121 is to attempt to understand the neural-cell-immune interaction to investigate the underlying mechani
124 t Tim-3 expression might represent a natural immune mechanism limiting viral spread.IMPORTANCE HIV in
125 GS-9688 treatment provides insights into the immune mechanisms that mediate this antiviral effect.
127 the two forms of diabetes mellitus; T1DM is immune mediated and T2DM is mediated by metabolic mechan
128 t to produce toxic byproducts that stimulate immune-mediated damage of hepatocytes and the biliary tr
130 netic risk variants associated with multiple immune-mediated diseases are a major determinant of inte
131 is often associated with a variety of other immune-mediated diseases, most commonly inflammatory bow
136 ute to altered immunity, the biogeography of immune-microbiome correlations among HEU children have n
139 herapies induce dynamic changes in the tumor immune microenvironment that vary by subtype and patholo
140 of HSC survival and migration and affect the immune microenvironment, especially macrophages in clear
141 acy of a microbial-based stimulus for innate immune mobilization depends on the correct selection of
142 room for development in macrophage-mediated immune modulation and macrophage-mediated drug delivery,
147 that are often intensified by host adaptive immune pathways to profoundly advance disease severity.
148 iched for glucocorticoid-regulated genes and immune pathways with some of these genes mediating the e
151 scriptomics identified neurotoxic CNS innate immune populations and may enable discovery of selective
154 iral humoral responses, define correlates of immune protection, and down-select candidate antivirals.
156 utophagy, have a key function in maintaining immune quiescence of tissue-resident macrophages, result
159 hat p53 plays a critical role in controlling immune recognition and responses in normal tissues as we
160 are at risk of the paradoxical TB-associated immune reconstitution inflammatory syndrome (TB-IRIS) wh
162 ings identify a pathway of estrogen-mediated immune regulation in the intestine, whereby homeostatic
163 y showing the importance of inflammation and immune regulation through the IL18-IL18RAP axis and anti
164 l KRAS-G12C inhibitor AMG 510 can potentiate immune rejection in combination with immune checkpoint b
165 downregulation of matrisome, cell cycle and immune related gene sets in Lcn2(-/-) mice exposed to CC
167 served 6 of 28 patients (21%) with grade >=3 immune-related adverse events, consisting of asymptomati
168 to immunotherapy and simultaneously identify immune-related adverse events, there are several challen
169 anterior uveitis, the most common ophthalmic immune-related AE, were 8209 per 100 000 for ipilimumab
170 ical pacemaker neurons express a rich set of immune-related genes mediating their interaction with th
171 een distantly related cell types such as the immune-related genes that were similarly expressed in im
172 ibitor (ICI) therapy is often accompanied by immune-related pathology, with an increasing occurrence
174 teine modification to alter the functions of immune-relevant proteins; however, our understanding of
179 ytokine production to promote an altered Th2 immune response following RSV infection that leads to mo
183 mechanisms contributing to the dysfunctional immune response of the elderly to the vaccine against in
185 viral reservoir along with an HIV-1-specific immune response seems to be key for the spontaneous func
186 protective immunity and amplifies the type 2 immune response that may favor the development of crypto
187 cal first step in understanding the earliest immune response to HIV-1 and suggest that changes in blo
189 s suggest that assessing the proinflammatory immune response to trauma exposure immediately after tra
190 earch is needed to understand how to monitor immune response to vaccines in immunosuppressed patients
193 kin cell biology, including activation of an immune response, a switch in cell metabolism and process
194 reatment in high altitude reduced the type 2 immune response, corrected the increased CRTH2 expressio
195 ation that lack rapid testing of the patient immune response, impeding clinicians from providing appr
196 r pharmacologically without compromising the immune response, providing a new approach to treat disea
197 m the thymus to the periphery and during the immune response, we discuss in broad terms developmental
198 d by the same drug (5-azacytidine) elicit an immune response, which may be important for patient's re
210 induced a remarkable increase of functional immune responses against GBS compared to the simple co-a
213 vaccine elicits strong humoral and cellular immune responses against pathogenic Ebola viruses and su
214 monstrate the emergence of pathogen-specific immune responses and a concomitant rise in plasma inflam
215 lamydia must evade both intracellular innate immune responses and adaptive cytotoxic T cell responses
216 tion, ranging from cellular communication to immune responses and the protein-driven mineralization o
217 alterations that blunt productive anti-tumor immune responses by directly or indirectly excluding eff
219 accine-induced activating versus suppressive immune responses in affording protection from HIV.IMPORT
222 pathogenesis, innate viral control, adaptive immune responses or the balance of inflammation and tiss
224 Overexpression of OsWAKL21.2 in rice induces immune responses similar to those activated by LipA trea
225 ts demonstrated that stromal Lama5 regulated immune responses through altering LN structures and T ce
228 e, Takahashi et al. found sex differences in immune responses to SARS-CoV-2 and the predictors of dis
229 ming immunization provides a method to focus immune responses to the desired target region, in the ab
230 ory function, CD40L has been used to enhance immune responses to vaccines, including candidate vaccin
231 Cancer immunotherapies enhance anti-tumor immune responses using checkpoint inhibitors, such as PD
232 s in antiviral defense, influencing adaptive immune responses via interactions with dendritic cells (
233 ge and thromboinflammation, dysregulation of immune responses, and maladaptation of ACE2-related path
234 , Salmonella Typhi, generates cross-reactive immune responses, which provide far greater resistance a
249 g of how rotavirus (RV) subverts host innate immune signaling has greatly increased over the past dec
251 disruption of USP7 interactions with innate immune signaling proteins TRAF3 and TRAF6, and that vIRF
252 in AGMs was associated with aberrant innate immune signaling, complement dysregulation, Th2 skewing,
254 equires combinatorial strategies to overcome immune suppression associated with the tumor microenviro
255 ndscape shaped by oncogenic drivers promotes immune suppression from the earliest stages of tumor inc
257 vascular endothelial growth factor-mediated immune suppression via angiogenesis inhibition may augme
258 h in turn regulates metabolic reprogramming, immune suppression, resistance to apoptosis, angiogenesi
262 with PD-1 plays an important role in evading immune surveillance; this can be overcome using PD-L1 or
263 we discuss potential mechanisms by which the immune system affects the central nervous system after s
264 te balance between the activity of the donor immune system against malignant and nonmalignant cells o
265 we describe a mechanism by which the innate immune system allows rapid quality check of absorbed flu
266 can still be recognised by the host's innate immune system and persistent BDG antigenaemia, in the ab
267 system is an intricate cascade of the innate immune system and plays a key role in microbial defense,
268 lysis highlighted the potential roles of the immune system and polycomb repressive complex 2 in patho
270 stigate the impacts of multiple stressors on immune system development in early life stage fishes.
272 activation (MIA) disrupts the central innate immune system during a critical neurodevelopmental perio
273 sociation between activation of the maternal immune system during pregnancy and increased risk of neu
275 lows unprecedented profiling of the adaptive immune system in submucosal and mucosal isolated lymphoi
276 minent role of the cellular component of the immune system in the development and perpetuation of AF.
277 crosstalk between metabolic tissues and the immune system in the inception and progression of obesit
280 the Treg compartment can skew the patient's immune system toward an anti-inflammatory phenotype and
281 ntibody titers and altered expression of the immune system, autophagy, and apoptosis pathway transcri
282 confer adaptive advantages on the mammalian immune system, especially during coinfection and during
288 ation by pathogens, and train the developing immune system.(1)(,)(2) However, humans are unique among
289 lying conditions, and those with compromised immune systems can develop severe disseminated disease.
290 ollowing emergence into secondary hosts with immune systems that diverge from those unique to bats.
291 nsmitting viruses that have evolved with bat immune systems will likely cause enhanced virulence foll
292 es, a diverse family of prokaryotic adaptive immune systems, have emerged as a biotechnological tool
294 cancer treatment modalities (e.g., gene and immune therapies) are profoundly changing the oncology l
295 D8(+) T cells and restored responsiveness to immune therapy, suggesting an indirect stromally targete
296 5, 2013, and March 7, 2019, 92 patients with immune thrombocytopenia were screened, of whom 74 (80%)
298 e to a tone paired with a weak footshock was immune to the IED, but chemogenetic activation of the LC
300 dation, the CLIV Score based on clinical and immune-virological parameters is potentially useful to s